These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 36738837

  • 1. Time-restricted eating improves measures of daily glycaemic control in people with type 2 diabetes.
    Parr EB, Steventon-Lorenzen N, Johnston R, Maniar N, Devlin BL, Lim KHC, Hawley JA.
    Diabetes Res Clin Pract; 2023 Mar; 197():110569. PubMed ID: 36738837
    [Abstract] [Full Text] [Related]

  • 2. Time-Restricted Eating as a Nutrition Strategy for Individuals with Type 2 Diabetes: A Feasibility Study.
    Parr EB, Devlin BL, Lim KHC, Moresi LNZ, Geils C, Brennan L, Hawley JA.
    Nutrients; 2020 Oct 22; 12(11):. PubMed ID: 33105701
    [Abstract] [Full Text] [Related]

  • 3. Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial.
    Andriessen C, Fealy CE, Veelen A, van Beek SMM, Roumans KHM, Connell NJ, Mevenkamp J, Moonen-Kornips E, Havekes B, Schrauwen-Hinderling VB, Hoeks J, Schrauwen P.
    Diabetologia; 2022 Oct 22; 65(10):1710-1720. PubMed ID: 35871650
    [Abstract] [Full Text] [Related]

  • 4. Comparing the effects of time-restricted eating on glycaemic control in people with type 2 diabetes with standard dietetic practice: A randomised controlled trial.
    Parr EB, Radford BE, Hall RC, Steventon-Lorenzen N, Flint SA, Siviour Z, Plessas C, Halson SL, Brennan L, Kouw IWK, Johnston RD, Devlin BL, Hawley JA.
    Diabetes Res Clin Pract; 2024 Oct 15; 217():111893. PubMed ID: 39414086
    [Abstract] [Full Text] [Related]

  • 5. Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial.
    Thomsen MN, Skytte MJ, Samkani A, Carl MH, Weber P, Astrup A, Chabanova E, Fenger M, Frystyk J, Hartmann B, Holst JJ, Larsen TM, Madsbad S, Magkos F, Thomsen HS, Haugaard SB, Krarup T.
    Diabetologia; 2022 Mar 15; 65(3):506-517. PubMed ID: 34993571
    [Abstract] [Full Text] [Related]

  • 6. The clinical effects of a carbohydrate-reduced high-protein diet on glycaemic variability in metformin-treated patients with type 2 diabetes mellitus: A randomised controlled study.
    Thomsen MN, Skytte MJ, Astrup A, Deacon CF, Holst JJ, Madsbad S, Krarup T, Haugaard SB, Samkani A.
    Clin Nutr ESPEN; 2020 Oct 15; 39():46-52. PubMed ID: 32859328
    [Abstract] [Full Text] [Related]

  • 7. Continuous Glucose Monitoring in Adolescents With Obesity: Monitoring of Glucose Profiles, Glycemic Excursions, and Adherence to Time Restricted Eating Programs.
    Naguib MN, Hegedus E, Raymond JK, Goran MI, Salvy SJ, Wee CP, Durazo-Arvizu R, Moss L, Vidmar AP.
    Front Endocrinol (Lausanne); 2022 Oct 15; 13():841838. PubMed ID: 35282464
    [Abstract] [Full Text] [Related]

  • 8. A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial.
    Skytte MJ, Samkani A, Petersen AD, Thomsen MN, Astrup A, Chabanova E, Frystyk J, Holst JJ, Thomsen HS, Madsbad S, Larsen TM, Haugaard SB, Krarup T.
    Diabetologia; 2019 Nov 15; 62(11):2066-2078. PubMed ID: 31338545
    [Abstract] [Full Text] [Related]

  • 9. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW, Riddlesworth TD, Ruedy KJ, Kollman C, Ahmann AJ, Bergenstal RM, Bhargava A, Bode BW, Haller S, Kruger DF, McGill JB, Polonsky W, Price D, Toschi E, DIAMOND Study Group.
    Lancet Diabetes Endocrinol; 2017 Sep 15; 5(9):700-708. PubMed ID: 28711468
    [Abstract] [Full Text] [Related]

  • 10. A randomised crossover trial: Exploring the dose-response effect of carbohydrate restriction on glycaemia in people with well-controlled type 2 diabetes.
    Al-Ozairi E, Reem AA, El Samad A, Taghadom E, Al-Kandari J, Abdul-Ghani M, Oliver N, Whitcher B, Guess N.
    J Hum Nutr Diet; 2023 Feb 15; 36(1):51-61. PubMed ID: 35560850
    [Abstract] [Full Text] [Related]

  • 11. The impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated type 2 diabetes: The SMBG study, a 12-month randomised controlled trial.
    Williams DM, Parsons SN, Dunseath GJ, Stephens JW, Luzio SD, Owens DR.
    Diabetes Metab Syndr; 2020 Feb 15; 14(2):101-106. PubMed ID: 31995784
    [Abstract] [Full Text] [Related]

  • 12. Effects of 8 wk of 16:8 Time-restricted Eating in Male Middle- and Long-Distance Runners.
    Brady AJ, Langton HM, Mulligan M, Egan B.
    Med Sci Sports Exerc; 2021 Mar 01; 53(3):633-642. PubMed ID: 32796255
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial.
    Battelino T, Bergenstal RM, Rodríguez A, Fernández Landó L, Bray R, Tong Z, Brown K.
    Lancet Diabetes Endocrinol; 2022 Jun 01; 10(6):407-417. PubMed ID: 35468321
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Real-Time Continuous Glucose Monitoring to Improve Effects of a Prescriptive Lifestyle Intervention in Type 2 Diabetes: A Pilot Study.
    Taylor PJ, Thompson CH, Luscombe-Marsh ND, Wycherley TP, Wittert G, Brinkworth GD.
    Diabetes Ther; 2019 Apr 01; 10(2):509-522. PubMed ID: 30706365
    [Abstract] [Full Text] [Related]

  • 15. The effects of 2 weeks of interval vs continuous walking training on glycaemic control and whole-body oxidative stress in individuals with type 2 diabetes: a controlled, randomised, crossover trial.
    Karstoft K, Clark MA, Jakobsen I, Müller IA, Pedersen BK, Solomon TP, Ried-Larsen M.
    Diabetologia; 2017 Mar 01; 60(3):508-517. PubMed ID: 27942800
    [Abstract] [Full Text] [Related]

  • 16. Effect of time restricted eating versus current practice in dietetics on glycaemic control and cardio-metabolic outcomes in individuals at risk of developing type 2 diabetes: Protocol for a multi-centre, parallel group, non-inferiority, randomised controlled trial.
    Charrouf R, Parr EB, Hutchison AT, Flint SA, Teong XT, Wittert G, Vincent AD, Brennan L, Devlin BL, Hawley JA, Heilbronn LK.
    Contemp Clin Trials; 2024 Sep 17; 146():107696. PubMed ID: 39299545
    [Abstract] [Full Text] [Related]

  • 17. The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.
    Heimbürger SMN, Hoe B, Nielsen CN, Bergmann NC, Hartmann B, Holst JJ, Vilsbøll T, Dejgaard TF, Christensen MB, Knop FK.
    Diabetologia; 2021 Nov 17; 64(11):2425-2431. PubMed ID: 34405256
    [Abstract] [Full Text] [Related]

  • 18. Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized clinical trial.
    Tay J, Thompson CH, Luscombe-Marsh ND, Wycherley TP, Noakes M, Buckley JD, Wittert GA, Yancy WS, Brinkworth GD.
    Diabetes Obes Metab; 2018 Apr 17; 20(4):858-871. PubMed ID: 29178536
    [Abstract] [Full Text] [Related]

  • 19. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
    Furler J, O'Neal D, Speight J, Blackberry I, Manski-Nankervis JA, Thuraisingam S, de La Rue K, Ginnivan L, Doyle R, Holmes-Truscott E, Khunti K, Dalziel K, Chiang J, Audehm R, Kennedy M, Clark M, Jenkins A, Lake AJ, Januszewski AS, Catchpool M, Liew D, Clarke P, Best J.
    Lancet Diabetes Endocrinol; 2020 Jan 17; 8(1):17-26. PubMed ID: 31862147
    [Abstract] [Full Text] [Related]

  • 20. Personalized Postprandial Glucose Response-Targeting Diet Versus Mediterranean Diet for Glycemic Control in Prediabetes.
    Ben-Yacov O, Godneva A, Rein M, Shilo S, Kolobkov D, Koren N, Cohen Dolev N, Travinsky Shmul T, Wolf BC, Kosower N, Sagiv K, Lotan-Pompan M, Zmora N, Weinberger A, Elinav E, Segal E.
    Diabetes Care; 2021 Sep 17; 44(9):1980-1991. PubMed ID: 34301736
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.